Latin America Hip Fracture Mortality Study
LAMOS
1 other identifier
observational
168
7 countries
15
Brief Summary
The purpose of this study is to estimate the survival proportion one year after surgery for intertrochanteric fracture in older adults in Latin America.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2013
Longer than P75 for all trials
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2012
CompletedFirst Posted
Study publicly available on registry
July 26, 2012
CompletedStudy Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedAugust 13, 2020
January 1, 2017
3.2 years
July 6, 2012
August 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Death
after 1 year
Secondary Outcomes (6)
Harris Hip Score
Screening/Preoperative and 90 ± 21 days
Parker Mobility Score
Screening/Preoperative, 30±7 days, 60±14 days, 90± 21 days, 365 (up to 425) days
Wound healing
30±7 days, 60±14 days, and 90± 21 days
Fracture healing
60±14 days and 90± 21 days
Anticipated surgical treatment-related adverse events
Postoperative (2 to 5 days), 30±7 days, 60±14 days, 90±21 days, 180±121 days, and 365 (up to 425) days
- +1 more secondary outcomes
Eligibility Criteria
Patients with surgically-treated hip fracture in Latin America
You may qualify if:
- Adults 60 years and older
- Diagnosis of an isolated intertrochanteric fracture (AO 31-A) confirmed by radiographic evaluation
- Primary surgical fracture treatment within 10 days after trauma
- No prior treatment for the fracture
- Ability to understand the content of the patient information / informed consent form
- Willingness and ability to participate in the clinical investigation according to the CIP
- Signed and dated IRB/EC-approved written informed consent
You may not qualify if:
- Polytrauma (ie, multiple injuries, whereof one or the combination of several injuries is life threatening)
- Pathologic fracture due to a disease other than osteoporosis (eg, tumor, metastasis)
- Active malignancy
- Class 5 and 6 of the American Society of Anesthesiologists (ASA) physical status classification (Appendix 2)
- Neurological and/or psychiatric disorders that would preclude reliable assessment (eg, Parkinson's disease, multiple sclerosis, severe depression)
- Recent history of substance abuse (ie, recreational drugs, alcohol) that would preclude reliable assessment
- Prisoner
- Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
- Noncompletion of patient baseline questionnaires
- Prior implant on the fractured hip
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (16)
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina
Hospital Vila Velha
Espírito Santo, Brazil
IOT - Instituto de Ortopedia de Traumatologia de Passo Fundo
Passo Fundo, Brazil
Hospital Municipal Miguel Couto
Rio de Janeiro, Brazil
Hospital das Clinicas da UNICAMP
São Paulo, Brazil
Hospital Irmandade da Santa Casa de Misericórdia de São Paulo
São Paulo, Brazil
Hospital São Paulo
São Paulo, Brazil
Universidad de São Paulo
São Paulo, Brazil
Hospital Clínico Pontificia Universidad Católica de Chile
Santiago, Chile
Hospital del Trabajador de Santiago
Santiago, Chile
Hospital Infantil de San José
Bogotá, Colombia
Hospital San Vicente de Paúl
San José, Costa Rica
Hospital Teodoro Maldonado Carbo
Guayaquil, Ecuador
Hospital de Traumatología y Ortopedia "Lomas Verdes"
Mexico City, Mexico
Hospital de Traumatología y Ortopedia UMAE #21
Monterrey, Mexico
Asociación Española Primera de Socorros Mutuos
Montevideo, Uruguay
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wiliam Belangero, Dr.med
Department of Orthopaedics and Traumatology, Hospital das Clinicas da UNICAMP, Brazil
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2012
First Posted
July 26, 2012
Study Start
January 1, 2013
Primary Completion
April 1, 2016
Study Completion
December 1, 2016
Last Updated
August 13, 2020
Record last verified: 2017-01